KEY
27
3
PRU
47
2
MS
70
6
SYY
41
2
XYL
31
2
ES
29
3
VRTX
49
2
CMCSA
52
3
URI
39
3
HOG
29
2
PFG
30
3
CPB
27
5
FLR
52
2
CHRW
54
3
MUR
43
3
VIX
7
-18
TRV
42
5
RCL
76
3
WFC
60
2
CRM
67
2
KEY
27
3
PRU
47
2
MS
70
6
SYY
41
2
XYL
31
2
ES
29
3
VRTX
49
2
CMCSA
52
3
URI
39
3
HOG
29
2
PFG
30
3
CPB
27
5
FLR
52
2
CHRW
54
3
MUR
43
3
VIX
7
-18
TRV
42
5
RCL
76
3
WFC
60
2
CRM
67
2
Financhill
Back

Adaptive Biotechnologies 10K Form

Sell
38

ADPT
Adaptive Biotechnologies

Last Price:
$6.45
Seasonality Move:
-30.57%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-09 10Q ADPT/Adaptive Biotechnologies Quarterly
2023-08-02 10Q ADPT/Adaptive Biotechnologies Quarterly
2023-05-03 10Q ADPT/Adaptive Biotechnologies Quarterly
2022-11-03 10Q ADPT/Adaptive Biotechnologies Quarterly
2022-08-03 10Q ADPT/Adaptive Biotechnologies Quarterly
2022-05-04 10Q ADPT/Adaptive Biotechnologies Quarterly

Receive ADPT News And Ratings

See the #1 stock for the next 7 days that we like better than ADPT

ADPT Financial Statistics

Sales & Book Value

Annual Sales: $170.3M
Cash Flow: $-27.4M
Price / Cash Flow: 0
Annual Sales: $1.52
Price / Book: 4.21

Profitability

EPS (TTM): -1.34000
Net Income (TTM): $-195.2M
Gross Margin: $94.7M
Return on Equity: -69.25%
Return on Assets: -31.06%

Adaptive Biotechnologies Earnings Forecast

Key Adaptive Biotechnologies Financial Ratios

  • The Gross Profit Margin over the past 18 years for ADPT is 55.63%.
  • The Selling, General & Administrative Expenses for ADPT have been equal to 101.31% of Gross Profit Margin.
  • The Research & Development expenses have been 71.72% of Revenue.
  • The Interest Expense is -6.13% of Operating Income.
  • The Net Earning history of ADPT is -132.29% of Total Revenues.
  • Per Share Earnings over the last 18 years have been positive in 5 years.

Adaptive Biotechnologies Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: ADPT
CUSIP: 00650F
Website: adaptivebiotech.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.52
Quick Ratio: 3.24

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ADPT Technical Analysis vs Fundamental Analysis

Sell
38
Adaptive Biotechnologies (ADPT) is a Sell

Is Adaptive Biotechnologies a Buy or a Sell?